Medical Ikkou Group Co.,Ltd.

Tokyo Stock Exchange 3353.T

Medical Ikkou Group Co.,Ltd. Price to Sales Ratio (P/S) on February 07, 2025: 0.21

Medical Ikkou Group Co.,Ltd. Price to Sales Ratio (P/S) is 0.21 on February 07, 2025, a -6.23% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

Medical Ikkou Group Co.,Ltd. 52-week high Price to Sales Ratio (P/S) is 0.25 on August 01, 2024, which is 19.96% above the current Price to Sales Ratio (P/S).
Medical Ikkou Group Co.,Ltd. 52-week low Price to Sales Ratio (P/S) is 0.18 on December 19, 2024, which is -13.60% below the current Price to Sales Ratio (P/S).
Medical Ikkou Group Co.,Ltd. average Price to Sales Ratio (P/S) for the last 52 weeks is 0.21.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

Tokyo Stock Exchange: 3353.T

Medical Ikkou Group Co.,Ltd.

CEO	Mr. Toshihisa Minamino
IPO Date	Nov. 26, 2004
Location	Japan
Headquarters	No. 36-25, Nishimarunouchi
Employees	1,431
Sector	Healthcare
Industries Drugstores & Retail Pharmacies Pharmaceuticals

Description

Medical Ikkou Group Co.,Ltd. operates dispensing pharmacies in Japan. The company is also involved in the operation of nursing homes, outpatient nursing care facilities, and home-visit nursing care facilities; wholesale of generic drugs; and rental of real estate properties, as well as invests in listed and unlisted stocks, M&A, etc. It operates 93 dispensing pharmacy stores. The company was founded in 1980 and is headquartered in Tsu, Japan.

Key trends

Past 5 years